Aberrant calcium signalling downstream of mutations in TP53 and the PI3K/AKT pathway genes promotes disease progression and therapy resistance in triple negative breast cancer

Triple-negative breast cancer (TNBC) is characterized as an aggressive form of breast cancer (BC) associated with poor patient outcomes. For the majority of patients, there is a lack of approved targeted therapies. Therefore, chemotherapy remains a key treatment option for these patients, but signif...

Descripción completa

Detalles Bibliográficos
Autores principales: Eustace, Alex J., Lee, Min Jie, Colley, Grace, Roban, Jack, Downing, Tim, Buchanan, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511797/
https://www.ncbi.nlm.nih.gov/pubmed/36176752
http://dx.doi.org/10.20517/cdr.2022.41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511797/
https://www.ncbi.nlm.nih.gov/pubmed/36176752
http://dx.doi.org/10.20517/cdr.2022.41

Ejemplares similares